Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
104.60    2.60 (2.55%)
Bid:
104.00
Ask:
105.20
Spread: 1.20 (1.154%)
Market Cap: £171.49m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

AGM & Interim Management Statement

14 May 2009 07:00

RNS Number : 1992S
Yule Catto & Co PLC
14 May 2009
 

14 May 2009

Yule Catto & Co plc 

AGM and Interim Management Statement

At today's Annual General Meeting of Yule Catto & Co plc, an international producer of speciality chemicals, Peter Wood, Chairman, will make the following statement, which comprises Yule Catto's Interim Management Statement for the period from 1 January 2009 to date.

Trading update

2009 has started satisfactorily given the very difficult macro economic environment. The Group has benefited from the weakness of sterling, and overall the Group has traded in line with management expectations.

In Polymer Chemicals, the substantial volume declines seen in the fourth quarter of 2008 persisted into 2009 although March was slightly better than the first two months of the year.

Pharma Chemicals had a good first quarter compared to what was a relatively weak start to 2008. Profits were in line with our expectations for a stronger full year performance in 2009. 

William Blythe, the remaining Impact Chemicals business was ahead of last year as expected, and benefited from the restructuring implemented at the end of the first quarter of 2008.

The Group announced a number of cost reduction initiatives with its full year 2008 results which are on track.

Following the successful refinancing at the year end with a new revolving finance facility and Malaysian term loan, the Group is making good progress on its debt reduction target. 

Looking forward we continue to expect the Pharma business to deliver higher profits than 2008, assisted by the favourable €/$ exchange rate and increased capacities for a number of products. Similarly William Blythe should continue to trade satisfactorily following its restructuring. Volume declines in Polymers moderated at the end of the first quarter but the outlook for the balance of the year remains uncertain. A large proportion of the Polymer Division's sales are in Europe and Asia and hence we are currently benefiting from the weakness of sterling. Given the uncertainty in our end markets, it is difficult to give any firm guidance on the outturn for Polymers for the full year and hence the Group as a whole.

Board Changes

Further to the retirement of Anthony Richmond-Watson, two other non executive directors will be retiring at this Annual General Meeting:- Dato' Seri Lee Oi Hian, who joined the Board in 1981 and is Chief Executive of Kuala Lumpur Kepong Bhd which has been a major shareholder in the Company since 1976; and Richard Hunting, an independent non executive director, who joined the Board in 2000 and has been Chairman of the Nomination Committee since 2001 and a member of the Audit Committee for nine years. I would like to thank all of them for their valuable contribution to the Group.

We are delighted to welcome Graham Menzies who joined the Board on 1 March this year. Graham's biographical details are in the circular that accompanied the 2008 Annual Report and he has been appointed as the Senior Independent Director after a distinguished career as a public company chief executive.

These changes complete the realignment of our Board structure and we believe that the Board, as currently constituted, is appropriate and balanced to serve the future needs of the Group.

ENQUIRIES:

YULE CATTO & Co plc

Tel: 01279 442791

Adrian Whitfield, Chief Executive 

David Blackwood, Finance Director 

 

HOGARTH PARTNERSHIP

Tel: 020 7357 9477

John Olsen

Andrew Jaques

Ian Payne

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSAJMATMMBBBBL
Date   Source Headline
4th Sep 20203:15 pmRNSDirector Declaration
6th Aug 20207:00 amRNSInterim Results for six months ended 30 June 2020
27th Jul 202010:00 amRNSPost Stabilisation Notice
16th Jul 20207:00 amRNSAppointment of Non-Executive Director
8th Jul 20204:16 pmRNSHolding(s) in Company
8th Jul 20204:14 pmRNSHolding(s) in Company
19th Jun 20207:00 amRNSSynthomer announces the pricing of senior notes
16th Jun 202011:54 amRNSPre Stabilisation Notice
16th Jun 202010:11 amRNSQ2 trading update
11th May 20205:21 pmRNSHolding(s) in Company
11th May 20209:03 amRNSDirector/PDMR Shareholding
11th May 20209:02 amRNSDirector/PDMR Shareholding
11th May 20208:59 amRNSDirector/PDMR Shareholding
11th May 20208:58 amRNSDirector/PDMR Shareholding
29th Apr 20203:17 pmRNSResult of AGM
29th Apr 20207:00 amRNSQ1 Trading and COVID-19 Update
1st Apr 20202:44 pmRNSCompletion of OMNOVA acquisition
1st Apr 20207:00 amRNSAnnual Financial Report
31st Mar 20207:00 amRNSDirector/PDMR Shareholding
31st Mar 20207:00 amRNSDirector/PDMR Shareholding
30th Mar 20207:00 amRNSAppointment of Deputy Chair and Chair-elect
30th Mar 20207:00 amRNSDirector/PDMR Shareholding
26th Mar 202010:17 amRNSEuropean Commission clearance for OMNOVA
23rd Mar 20207:00 amRNSDirector/PDMR Shareholding
16th Mar 20209:50 amRNSDirector/PDMR Shareholding
13th Mar 20205:29 pmRNSDirector/PDMR Shareholding
9th Mar 20202:45 pmRNSHolding(s) in Company
5th Mar 20207:00 amRNSPreliminary Results for the year ended 31 Dec 2019
31st Jan 20209:36 amRNSDirector Declaration
15th Jan 20202:21 pmRNSAcquisition of OMNOVA receives EC clearance
6th Dec 20197:00 amRNSAppointment of Broker
13th Nov 20192:53 pmRNSDirector/PDMR Shareholding
11th Nov 20197:00 amRNSDirector Declaration
25th Oct 20197:00 amRNSQ3 Trading Update
22nd Oct 20197:00 amRNSAGM Statement
11th Oct 20197:00 amRNSOmnova shareholders approval
14th Aug 20193:25 pmRNSHolding(s) in Company
13th Aug 201912:33 pmRNSDirector/PDMR Shareholding
6th Aug 20197:00 amRNSInterim Results for 6 months ended 30 June 2019
2nd Aug 201910:29 amRNSHolding(s) in Company
1st Aug 20199:05 amRNSHolding(s) in Company
31st Jul 201910:51 amRNSResults of Extraordinary General Meeting
30th Jul 20191:07 pmRNSDirector/PDMR Shareholding
30th Jul 20191:03 pmRNSDirector/PDMR Shareholding
30th Jul 20191:02 pmRNSDirector/PDMR Shareholding
30th Jul 20191:01 pmRNSDirector/PDMR Shareholding
30th Jul 201912:59 pmRNSDirector/PDMR Shareholding
30th Jul 201912:57 pmRNSDirector/PDMR Shareholding
30th Jul 201912:57 pmRNSDirector/PDMR Shareholding
30th Jul 201912:55 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.